Fibrosis

"Fibrosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.

Descriptor ID	D005355
MeSH Number(s)	C23.550.355
Concept/Terms	Fibrosis Fibrosis Fibroses Cirrhosis Cirrhosis

Below are MeSH descriptors whose meaning is more general than "Fibrosis".

Diseases [C]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Fibrosis [C23.550.355]

Below are MeSH descriptors whose meaning is related to "Fibrosis".

Below are MeSH descriptors whose meaning is more specific than "Fibrosis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Fibrosis" by people in this website by year, and whether "Fibrosis" was a major or minor topic of these publications.

Bar chart showing 127 publications over 25 distinct years, with a maximum of 10 publications in 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	0	1	1
2002	1	4	5
2003	0	3	3
2004	0	3	3
2005	0	2	2
2006	0	4	4
2007	2	4	6
2008	2	5	7
2009	1	6	7
2010	2	3	5
2011	1	6	7
2012	0	7	7
2013	2	6	8
2014	0	6	6
2015	0	2	2
2016	1	8	9
2017	1	6	7
2018	1	2	3
2019	0	3	3
2020	0	4	4
2021	0	3	3
2022	0	8	8
2023	0	10	10
2024	2	3	5
2025	0	2	2

Below are the most recent publications written about "Fibrosis" by people in Profiles.

Tsai PS, Wu KC, Wu CH. The metal-organic framework MIL-100(Fe) and ferric citrate as potential counteracting biomaterials against osteoarthritis-induced articular inflammation and fibrosis. Biomed Pharmacother. 2025 Oct; 191:118519.

View in: PubMed
Papapostolou S, Iles L, O'Brien J, Gutman SJ, Ellims A, Hare J, Stub D, Moir S, Taylor AJ. The Antifibrotic Effects of Eplerenone in Hypertrophic Cardiomyopathy: A Randomized Clinical Trial. JACC Heart Fail. 2025 Jul; 13(7):102415.

View in: PubMed
Ishihara T, Kato K, Matsumoto K, Tanaka M, Hara A, Shiraki Y, Morisaki H, Urano Y, Ando R, Ito K, Mii S, Esaki N, Furuhashi K, Takefuji M, Suganami T, Murohara T, Enomoto A. Meflin/ISLR is a marker of adipose stem and progenitor cells in mice and humans that suppresses white adipose tissue remodeling and fibrosis. Genes Cells. 2024 Oct; 29(10):902-920.

View in: PubMed
Gallo PM, Chain RW, Xu J, Whiteman LM, Palladino A, Caricchio R, Costa-Reis P, Sullivan KE, Gallucci S. EGFR-ErbB2 dual kinase inhibitor lapatinib decreases autoantibody levels and worsens renal disease in Interferon a-accelerated murine lupus. Int Immunopharmacol. 2024 Oct 25; 140:112692.

View in: PubMed
Yin Q, Tang TT, Lu XY, Ni WJ, Yin D, Zhang YL, Jiang W, Zhang Y, Li ZL, Wen Y, Gan WH, Zhang AQ, Lv LL, Wang B, Liu BC. Macrophage-derived exosomes promote telomere fragility and senescence in tubular epithelial cells by delivering miR-155. Cell Commun Signal. 2024 07 10; 22(1):357.

View in: PubMed
Ni WJ, Li ZL, Wen XL, Ji JL, Liu H, Yin Q, Jiang LY, Zhang YL, Wen Y, Tang TT, Jiang W, Lv LL, Gan WH, Liu BC, Wang B. HIF-1a and adaptor protein LIM and senescent cell antigen-like domains protein 1 axis promotes tubulointerstitial fibrosis by interacting with vimentin in angiotensin II-induced hypertension. Br J Pharmacol. 2024 Sep; 181(17):3098-3117.

View in: PubMed
Bhatt HN, Diwan R, Estevao IL, Dong R, Smith J, Xiao C, Agarwal SK, Nurunnabi M. Cadherin-11 targeted cell-specific liposomes enabled skin fibrosis treatment by inducing apoptosis. J Control Release. 2024 Jun; 370:110-123.

View in: PubMed
Diwan R, Bhatt HN, Beaven E, Nurunnabi M. Emerging delivery approaches for targeted pulmonary fibrosis treatment. Adv Drug Deliv Rev. 2024 01; 204:115147.

View in: PubMed
Segan L, Chieng D, Sugumar H, Voskoboinik A, Ling LH, Costello B, Azzopardi S, Nderitu Z, Parameswaran R, Amerena J, McLellan AJ, Lee G, Morton J, Joseph S, Wong M, Taylor A, Kalman JM, Kistler PM, Prabhu S. The impact of age on ablation outcomes in AF-mediated cardiomyopathy. J Cardiovasc Electrophysiol. 2023 10; 34(10):2065-2075.

View in: PubMed
Niture S, Gadi S, Qi Q, Rios-Colon L, Khatiwada S, Fernando RA, Levine KE, Kumar D. Cyanotoxins Increase Cytotoxicity and Promote Nonalcoholic Fatty Liver Disease Progression by Enhancing Cell Steatosis. Toxins (Basel). 2023 06 25; 15(7).

View in: PubMed

People

Explore

Similar Concepts

Top Journals